STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.
- Revenue
- +8.79%
- EPS
- +12.8%
- Free cash flow
- +43.6%
- Total debt
- −0.21%
Quarter to September 2026, against a year earlier
Follow STE
Alert me
STERIS plc (STE) Operating cash flow
STERIS plc's operating cash flow for fiscal 2026 was $1.3B, up 16.8% from $1.1B in fiscal 2025. Over the twelve months to 30 September 2026 it was $1.3B. Over the past ten years it has ranged from $246.0M (fiscal 2015) to $1.3B (fiscal 2026) — the current reading is the highest in ten years. Operating cash flow has risen for 4 consecutive fiscal years. STERIS plc ranks 11th of 149 Medical Devices companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2026 | $1.3B | 16.84% |
| FY2025 | $1.1B | 17.96% |
| FY2024 | $973.3M | 28.58% |
| FY2023 | $756.9M | 10.53% |
| FY2022 | $684.8M | (0.70%) |
| FY2021 | $689.6M | 16.78% |
| FY2020 | $590.6M | 9.46% |
| FY2019 | $539.5M | 17.89% |
| FY2018 | $457.6M | 7.91% |
| FY2017 | $424.1M | 66.52% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $289.0M | (21.27%) |
| Jun 2026 | $367.1M | 9.45% |
| Mar 2026 | $335.4M | 12.47% |
| Dec 2025 | $298.2M | 3.61% |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | $3.1B |
| PHG Koninklijke Philips N.V. compare | $2.9B |
| GEHC GE HealthCare Technologies Inc. compare | $2.4B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $1.9B |
| DXCM DexCom, Inc. compare | $1.4B |
| STE STERIS plc | $1.3B |
| GMED Globus Medical, Inc. compare | $925.9M |
| PEN Penumbra, Inc. compare | $261.0M |
| GKOS Glaukos Corporation compare | $47.7M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on STE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement